PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
International Biotechnology Trust plc (IBT.L)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINGB0004559349
SectorFinancial Services
IndustryCollective Investments

Highlights

Market Cap£250.50M
EPS (TTM)£0.48
PE Ratio14.21
Total Revenue (TTM)£48.62M
Gross Profit (TTM)£45.96M
EBITDA (TTM)£28.72M
Year Range£524.80 - £720.00

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of £10,000 in International Biotechnology Trust plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%AprilMayJuneJulyAugustSeptember
7.30%
3.88%
IBT.L (International Biotechnology Trust plc)
Benchmark (^GSPC)

Returns By Period

International Biotechnology Trust plc had a return of 8.47% year-to-date (YTD) and 11.97% in the last 12 months. Over the past 10 years, International Biotechnology Trust plc had an annualized return of 11.46%, outperforming the S&P 500 benchmark which had an annualized return of 10.85%.


PeriodReturnBenchmark
Year-To-Date8.47%17.79%
1 month-0.00%0.18%
6 months7.30%7.53%
1 year11.97%26.42%
5 years (annualized)5.88%13.48%
10 years (annualized)11.46%10.85%

Monthly Returns

The table below presents the monthly returns of IBT.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20242.65%3.79%-4.09%-6.10%1.62%2.88%10.35%-2.30%8.47%
2023-0.71%-1.57%-3.91%0.45%-0.75%-1.06%0.05%0.63%-2.02%-11.25%3.21%13.59%-4.92%
2022-15.59%0.79%0.47%-1.17%-1.82%6.77%4.23%-3.42%1.30%-1.52%6.46%4.05%-1.47%
20210.86%-4.73%-5.99%0.34%-2.50%0.69%-0.02%2.31%0.75%-2.99%2.52%4.43%-4.74%
2020-6.75%-6.90%10.37%13.09%12.76%1.05%-3.20%-0.27%9.04%-1.63%4.73%1.32%35.65%
20197.02%0.98%1.95%-0.32%-2.24%4.25%4.26%-2.30%-5.03%-0.33%6.64%-1.18%13.73%
20180.40%-4.56%-6.48%1.46%7.01%2.52%9.51%3.92%-0.88%-12.46%3.56%-4.49%-2.59%
20171.84%7.57%1.02%-1.68%-2.39%5.07%3.74%2.02%-3.04%-0.83%1.50%2.63%18.29%
2016-20.55%-1.16%-3.29%4.62%4.65%1.67%15.85%-6.13%10.05%-2.37%4.63%-1.65%1.62%
201514.67%-2.56%8.99%-5.10%7.42%-1.82%7.78%-5.24%-17.50%11.87%3.05%3.19%22.18%
20142.34%8.09%-15.19%-3.39%2.63%7.51%-3.09%8.54%2.15%20.31%7.31%6.81%48.16%
20137.87%-0.44%6.03%9.30%3.61%-1.74%5.81%0.09%6.51%5.41%-4.14%3.28%49.14%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of IBT.L is 63, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of IBT.L is 6363
IBT.L (International Biotechnology Trust plc)
The Sharpe Ratio Rank of IBT.L is 6767Sharpe Ratio Rank
The Sortino Ratio Rank of IBT.L is 6060Sortino Ratio Rank
The Omega Ratio Rank of IBT.L is 5656Omega Ratio Rank
The Calmar Ratio Rank of IBT.L is 6666Calmar Ratio Rank
The Martin Ratio Rank of IBT.L is 6464Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for International Biotechnology Trust plc (IBT.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


IBT.L
Sharpe ratio
The chart of Sharpe ratio for IBT.L, currently valued at 0.64, compared to the broader market-4.00-2.000.002.000.64
Sortino ratio
The chart of Sortino ratio for IBT.L, currently valued at 1.07, compared to the broader market-6.00-4.00-2.000.002.004.001.07
Omega ratio
The chart of Omega ratio for IBT.L, currently valued at 1.12, compared to the broader market0.501.001.502.001.12
Calmar ratio
The chart of Calmar ratio for IBT.L, currently valued at 0.46, compared to the broader market0.001.002.003.004.005.000.46
Martin ratio
The chart of Martin ratio for IBT.L, currently valued at 2.08, compared to the broader market-10.00-5.000.005.0010.0015.0020.002.08
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.06, compared to the broader market-4.00-2.000.002.002.06
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-6.00-4.00-2.000.002.004.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.37, compared to the broader market0.501.001.502.001.37
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.85, compared to the broader market0.001.002.003.004.005.001.85
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 11.09, compared to the broader market-10.00-5.000.005.0010.0015.0020.0011.09

Sharpe Ratio

The current International Biotechnology Trust plc Sharpe ratio is 0.64. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of International Biotechnology Trust plc with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00AprilMayJuneJulyAugustSeptember
0.64
1.34
IBT.L (International Biotechnology Trust plc)
Benchmark (^GSPC)

Dividends

Dividend History

International Biotechnology Trust plc granted a 4.16% dividend yield in the last twelve months. The annual payout for that period amounted to £0.28 per share.


PeriodTTM2023202220212020201920182017
Dividend£0.28£0.28£0.30£0.30£0.27£0.26£0.41£0.23

Dividend yield

4.16%4.38%4.21%4.00%3.26%4.24%7.19%3.68%

Monthly Dividends

The table displays the monthly dividend distributions for International Biotechnology Trust plc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024£0.00£0.00£0.00£0.00£0.00£0.00£0.15£0.00£0.00£0.15
2023£0.00£0.00£0.00£0.00£0.00£0.00£0.14£0.00£0.00£0.00£0.00£0.14£0.28
2022£0.00£0.00£0.00£0.00£0.00£0.00£0.00£0.16£0.00£0.00£0.00£0.14£0.30
2021£0.00£0.00£0.00£0.00£0.00£0.00£0.14£0.00£0.00£0.00£0.00£0.16£0.30
2020£0.00£0.00£0.00£0.00£0.00£0.00£0.12£0.00£0.00£0.00£0.00£0.14£0.27
2019£0.00£0.00£0.00£0.00£0.00£0.00£0.14£0.00£0.00£0.00£0.00£0.12£0.26
2018£0.14£0.00£0.00£0.00£0.00£0.00£0.00£0.14£0.00£0.00£0.00£0.14£0.41
2017£0.12£0.00£0.00£0.00£0.00£0.00£0.00£0.12£0.00£0.00£0.00£0.00£0.23

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%4.2%
International Biotechnology Trust plc has a dividend yield of 4.16%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%58.4%
International Biotechnology Trust plc has a payout ratio of 58.43%, which is quite average when compared to the overall market. This suggests that International Biotechnology Trust plc strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%AprilMayJuneJulyAugustSeptember
-7.18%
-3.15%
IBT.L (International Biotechnology Trust plc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the International Biotechnology Trust plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the International Biotechnology Trust plc was 92.23%, occurring on Dec 8, 1998. Recovery took 3804 trading sessions.

The current International Biotechnology Trust plc drawdown is 7.18%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.23%Oct 17, 1996491Dec 8, 19983804Oct 31, 20144295
-38.71%Jul 24, 2015138Feb 8, 2016269Mar 1, 2017407
-33.12%Jun 18, 199621Jul 16, 199654Oct 16, 199675
-29.74%Feb 11, 2021312May 9, 2022
-28.76%Sep 4, 2018391Mar 18, 202021Apr 20, 2020412

Volatility

Volatility Chart

The current International Biotechnology Trust plc volatility is 3.78%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%AprilMayJuneJulyAugustSeptember
3.78%
4.71%
IBT.L (International Biotechnology Trust plc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of International Biotechnology Trust plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of International Biotechnology Trust plc compared to its peers in the Collective Investments industry.


PE Ratio
50.0100.0150.0200.0250.014.2
The chart displays the price to earnings (P/E) ratio for IBT.L in comparison to other companies of the Collective Investments industry. Currently, IBT.L has a PE value of 14.2. This PE ratio falls in the average range for the industry.
PEG Ratio
0.00.0
The chart displays the price to earnings to growth (PEG) ratio for IBT.L in comparison to other companies of the Collective Investments industry. Currently, IBT.L has a PEG value of 0.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for International Biotechnology Trust plc.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items